Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Stimulation of the GLP-1 receptors was additionally reported to provide with several advantages including the weight loss, enhanced glycemic control, improved cardiovascular and liver functions
Nausea: A very common side effect of GLP-1s
The Chinese government's 14th Five-Year Plan for healthcare specifically identifies diabetes management as a chronic disease prevention priority, with investment in guideline-based pharmacotherapy programs that are driving adoption of evidence-based GLP-1 therapy in public healthcare settings Middle East & Africa and Latin America GLP-1 Receptor Agonist Market Insights The Middle East represents a commercially interesting GLP-1 market because the Gulf states combine high rates of type 2 diabetes and obesity the UAE's adult obesity rate exceeds 37%, among the world's highest with high-income consumer populations and expanding private health insurance coverage
Greater Flexibility in Dosing Decisions Another commonly cited reason is the desire for flexibility
Most patients lose between 50-60% of their excess weight within the first year post-surgery
Originally developed to manage type 2 diabetes, these medications mimic the GLP-1 hormone, which plays a key role in regulating appetite, slowing gastric emptying, and enhancing feelings of fullness
US$ 29.55
US$ 25.66
US$ 29.60
US$ 22.56
US$ 23.49
US$ 25.13
US$ 29.49
US$ 25.79
